First Interim Analysis of the #CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal #Cancer
www.mdpi.com/2673-9992/39...

By Simon Nannini
From the 2025 International Kidney Cancer Symposium

#mRCC